Independent education resourceInformation here does not replace care from a qualified health professional.
Peptide Therapy GuideClear peptide education

Understand the source comparison

SLU-PP-332 vs Standard Muscle Preservation Approaches: Protocol Comparison

Before committing to any muscle preservation strategy, understanding how SLU-PP-332's mechanism differs from traditional approaches helps clarify why certain protocols succeed where others fail. SLU-PP-332 (ERR agonist) Activates ERRα/ERRγ to upregulate mitoch

No winner is assigned.

This page preserves a source comparison for education. It does not add a rating, recommendation or clinical judgment.

  • Before committing to any muscle preservation strategy, understanding how SLU-PP-332's mechanism differs from traditional approaches helps clarify why certain protocols succeed where others fail.
  • SLU-PP-332 (ERR agonist)
  • Activates ERRα/ERRγ to upregulate mitochondrial biogenesis and fat oxidation in skeletal muscle
  • 92–97% of baseline lean mass maintained
  • Requires precise dosing, storage at 2–8°C, and concurrent resistance training. Ineffective without mechanical stimulus
  • Most mechanistically sound for metabolic preservation; synergizes with training rather than replacing it
  • High-protein diet alone (2.2g/kg)
  • Provides amino acids for protein synthesis; leucine threshold for mTOR activation
  • 85–90% lean mass retained in moderate deficit
  • Protective effect diminishes in aggressive deficits (>25% below maintenance); doesn't address metabolic signaling collapse
  • Essential foundation but insufficient alone; must pair with training and ideally metabolic support
  • Resistance training (3–4x/week)
  • Mechanical stimulus signals muscle retention; neuromuscular recruitment preserves tissue
  • 88–93% lean mass retained when volume/intensity maintained
  • Recovery capacity limited under deficit; volume must be reduced 10–20% to avoid overtraining
  • Non-negotiable for preservation but benefits plateau without metabolic or nutritional optimization
  • Anabolic compounds (testosterone, SARMs)
  • Direct androgen receptor activation; increases protein synthesis and nitrogen retention
  • 95–100% lean mass retained; often gain muscle during deficit
  • Significant endocrine suppression post-cycle; legal/health risks; requires PCT (post-cycle therapy)
  • Effective but carries risks that ERR agonism avoids; not appropriate for general population
  • Beta-alanine + creatine supplementation
  • Buffers intramuscular pH; increases phosphocreatine stores for ATP regeneration
  • 87–91% lean mass retained (marginal improvement over baseline)
  • Indirect mechanism; supports training performance but doesn't address metabolic signaling
  • Useful adjunct for performance but minimal direct preservation effect independent of training quality
  • The comparison reveals a critical insight: SLU-PP-332 addresses the metabolic signaling collapse that occurs during energy deficit. The root cause other approaches ignore. High protein and resistance training are necessary but not sufficient; they can't override the hormonal and enzymatic shifts that promote muscle catabolism when calories drop. ERR agonism changes the metabolic context so the body preferentially oxidizes fat rather than breaking down muscle for gluconeogenesis.